Combinatorial library design for diversity, cost efficiency, and drug-like character

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Traditional combinatorial library design focuses on diversity or target similarity, often yielding compounds unsuitable for further development.
• High-throughput screening hits may possess undesirable properties, hindering progression into medicinal chemistry pipelines.

Purpose of the Study:

• To present novel software for designing combinatorial library subsets with optimized multiple parameters.
• To enable simultaneous optimization of library diversity, target similarity, drug-likeness, reagent cost, and synthetic efficiency.

Main Methods:

• Development of a computational tool for combinatorial library design.
• Integration of multiple optimization criteria including diversity, similarity, drug-likeness, cost, and synthesis efficiency.
• Application of the software to design diverse, drug-like, and cost-effective chemical libraries.

Main Results:

• Libraries can be designed to include drug-like molecules with minimal compromise on diversity.
• The cost of library synthesis, based on reagent expenses, can be effectively managed.
• Software enables optimization for minimizing deconvolution challenges and maximizing predicted active molecules while ensuring synthetic feasibility.

Conclusions:

• The developed software offers a powerful approach to designing combinatorial libraries with improved properties for drug discovery.
• Simultaneous optimization of multiple library design parameters leads to more viable compounds for medicinal chemistry.
• This method enhances the efficiency and success rate of early-stage drug discovery efforts.